11
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Epidermal Growth Factor and Transforming Growth Factor Alpha in Duodenal Ulcer and Non-Ulcer Dyspepsia Patients before and after Helicobacter pylori Eradication

Pages 143-151 | Published online: 08 Jul 2009

References

  • Coffey RJ, Gangarosa LM, Damstrup L, Dempsey PJ. Basic actions of transforming growth factor-α and related peptides. Eur J Gastroenterol 1995;7:923–7.
  • Konturek PCh, Konturek SJ, Brzozowski T, Ernst H. Epidermal growth factor and transforming growth factor a: role in protection and healing of gastric mucosal lesions. Eur J Gastroenterol 1995;7:933–8.
  • Hernandez-Sotomayor TSM, Carpenter G. Epidermal growth factor receptor: elements of intracellular communication. J Membrane Biol 1992;128:81–9.
  • Playford RJ, Boulton R, Ghatei MA, Bloom SR, Wright NA, Goodlad RA. Comparison of the effects of transforming growth factor a and epidermal growth factor on gastrointestinal proliferation and hormone release. Digestion 1996;57:362–7.
  • Uribe JM, Barrett KE. Nonmitogenic actions of growth factors: an integrated view of their role in intestinal physiology and pathophysiology. Gastroenterology 1997;112:255–68.
  • Konturek JW, Bielanski W, Konturek SJ, Bogdal J, Oleksy J. Distribution and release of epidermal growth factor in man. Gut 1989;30:1194–200.
  • Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 1975;257:325–7.
  • Elder JB, Williams G, Lacey E, Gregory H. Cellular localization of human urogastrone/epidermal growth factor. Nature 1978; 271:466–7.
  • Poulssen SS, Nexo E, Olsen PS. Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry 1986;85:389–94.
  • Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell linkage by mucosal ulceration in human gastrointestinal stem sells. Nature 1990;343:82–5.
  • Alison MR, Nasim MM, Anilkumar TV, Sarraf CE. Transforming growth factor immunoreactivity in a variety of epithelial tissues. Cell Prolif 1993;26:449–60.
  • Thomas DM, Nasim MM, Gullick WJ, Alison MR. Immunoreactivity of transforming growth factor alpha in the normal adult gastrointestinal tract. Gut 1992;33:628–31.
  • Polk WH Jr, Dempsey PJ, Russell WE, Brown PI, Beauchamp D, Barnard JA, et al. Increased production of transforming growth factor alpha following acute gastric injury. Gastroenterology 1992;102:1467–74.
  • Konturek PC, Ernst H, Brzozowski T, Ihlm A, Hahn EG, Konturek SJ. Expression of epidermal growth factor and transforming growth factor-α after exposure of rat gastric mucosa to stress. Scand J Gastroenterol 1996;31:209–16.
  • Konturek PC, Brzozowski T, Konturek SJ, Ernst H, Drozdowicz D, Pajdo R, et al. Expression of epidermal growth factor and transforming growth factor alpha during ulcer healing. Scand J Gastroenterol 1997;32:6–15.
  • Lee H, Hansson H-A, Norström E, Helander H. Immunoreactivities for epidermal growth factor (EGF) and for receptors in rats with gastric ulcers. Cell Tissue Res 1991;265:211–8.
  • Bielanski W, Konturek SJ. New approach to 13C-urea breath test: capsule-based modification with low dose of 13C-urea in the diagnosis of Helicobacter pylori infection. J Physiol Pharmacol 1996;47:545–53.
  • Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991;6:209–22.
  • Peek RM, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995;71:760–70.
  • Tal M, King CR, Kraus MM, Ullrich A, Schlessinger J, Givol D. Human HER 2(neu) promoter: evidence for multiple mechanisms for transcriptional initiation. Mol Cell Biol 1987;7:2597–601.
  • Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV. Human transforming growth factor alpha: precursor structure and expression in E.coli. Cell 1984;38: 287.
  • Jankowski J, Al-Rawi JH, Johnston DA, Hopwood D, Filipe MI, Coghill G, et al. Growth regulatory peptides in gastric mucosa. Clin Sci 1992;82:581–7.
  • Konturek JW, Gillessen A, Konturek SJ, Domschke W. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut 1995;37:482–7.
  • Konturek PC, Ernst H, Konturek SJ, Bobrzynski A, Faller G, Klinger C, et al. Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori. Gut 1997;40:463–9.
  • Calabro A, Orsini B, Brocchi A, Falchini M, Fedi P, Surrenti C. Gastric juice immunoreactivity epidermal growth factor levels in patients with peptic ulcer disease. Am J Gastroenterol 1990; 85:404–7.
  • Tunio AM, Hobsley M. Epidermal growth factor in saliva and gastric juice in response to histamine. Gut 1995;37:335–9.
  • Marcinkiewicz M, Vander Linden B, Peura DA, Goldin G, Paralisi S, Sarosiek J. Impact of Helicobacter pylori colonization on immunoreactive epidermal growth factor and transforming growth factor-α in gastric juice. Its potential pathogenetic implications. Dig Dis Sci 1996;41:2150–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.